Saturday, July 24, 2021
wellness India Expo
Home Tags GlobalData

Tag: GlobalData

China focuses on next-generation intranasal COVID-19 vaccines amid rising mutant strains

Several pharmaceutical companies across the world have started working on the inhaled vaccine formulations and China is also developing next-generation intranasal COVID-19 vaccines, says GlobalData....................

Approval in India paves way for Bharat Biotech to take Covaxin...

Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................

Chinese biotech revolution to have highest impact globally in 2019, says...

The government-supported Chinese biotech revolution will bring forth many Chinese drug developers to compete with well-established multinational drug companies...............

Gene-editing a significant leap forward but only if used ethically

In the backdrop of the claims made by Chinese scientists, He Jiankui that he has edited the human genome embryo, the experts have pointed out that it has not been proven to be safe, and acceptable ethical guidelines have yet to be fully drafted or agreed upon...…………….

AstraZeneca well placed to use Medtech to expand in Chinese healthcare...

The Chinese Internet giants will develop smart health services, AI-assisted screening and diagnosis tools for the British pharma giant...……….

Post NHS approval, sky is the limit for Novartis’ CAR-T therapy:...

According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….

US-China trade war offers window of opportunity for Indian pharma sector

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

Regenerative medicine can displace current treatments in CVMD space, says GlobalData

As per the GlobalData, key opinion leaders interviewed by it are eager to have these novel treatments at their disposal, especially for patients with advanced heart failure...………..

Holistic approach may bring true innovation to pharma world, says GlobalData

Major pharma companies are facing massive challenges in developing truly innovative drugs and to minimize risk in internal R&D, they have been mainly relying on outside innovation by biotech firms.................

Artificial intelligence to advance drug discovery

The pharma companies are partnering with artificial intelligence firms in a bid to advance drug discovery............